CD44 and cancer: As a result, the miR-5088-5p inhibitor decreased in IR-induced sphere formation ability (Fig. 3D) by reducing cancer stem-like cell (CSC) marker proteins, such as Oct4, Nanog, Sox2, CD133, and CD44 (Fig. 3E).